Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

Journal of Hepatology

Volumn 58, Issue 2, 2013, Pages 234-239

  Trebicka, Jonel ^b   Anadol, Evrim ^b   Elfimova, Natalia ^a   Strack, Ingo ^a   Roggendorf, Michael ^c   Viazov, Sergei ^c   Wedemeyer, Inga ^a   Drebber, Uta ^a   Rockstroh, Jürgen ^b   Sauerbruch, Tilman ^b   Dienes, Hans Peter ^a   Odenthal, Margarete ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Chronic HCV infection; Hepatic fibrosis; Hepatic inflammation; miR 122

Indexed keywords

MICRORNA 122;

ARTICLE; BLOOD LEVEL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BIOPSY; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MICRORNAS; SEVERITY OF ILLNESS INDEX;

EID: 84872376663     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.10.015     Document Type: Article

References (53)

1. D. Schuppan, and N.H. Afdhal Liver cirrhosis Lancet 371 2008 838 851
2. G.H. Brundtland From the World Health Organization. Reducing risks to health, promoting healthy life JAMA 288 2002 1974
3. R. Bataller, and D.A. Brenner Liver fibrosis J Clin Invest 115 2005 209 218
4. T. Poynard, P. Mathurin, C.L. Lai, D. Guyader, R. Poupon, and M.H. Tainturier A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 2003 257 265
5. J. Wakim-Fleming, and K.D. Mullen Long-term management of alcoholic liver disease Clin Liver Dis 9 2005 135 149
6. D. Rincon, C. Ripoll, O. Lo Iacono, M. Salcedo, M.V. Catalina, and E. Alvarez Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis Am J Gastroenterol 101 2006 2269 2274
7. W. Abdi, J.C. Millan, and E. Mezey Sampling variability on percutaneous liver biopsy Arch Intern Med 139 1979 667 669
8. B. Maharaj, R.J. Maharaj, W.P. Leary, R.M. Cooppan, A.D. Naran, and D. Pirie Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525
9. A.A. Bravo, S.G. Sheth, and S. Chopra Liver biopsy N Engl J Med 344 2001 495 500
10. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
11. L. Sandrin, B. Fourquet, J.M. Hasquenoph, S. Yon, C. Fournier, and F. Mal Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
12. E. Nguyen-Khac, and D. Capron Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan) Eur J Gastroenterol Hepatol 18 2006 1321 1325
13. G. Millonig, S. Friedrich, S. Adolf, H. Fonouni, M. Golriz, and A. Mehrabi Liver stiffness is directly influenced by central venous pressure J Hepatol 52 2010 206 210
14. A. Koch, A. Horn, H. Duckers, E. Yagmur, E. Sanson, and J. Bruensing Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU Crit Care 15 2011 R266
15. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
16. A. Noetel, M. Kwiecinski, N. Elfimova, J. Huang, and M. Odenthal MicroRNA are central players in anti- and profibrotic gene regulation during liver fibrosis Front Physiol 3 2012 49
17. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, and E.L. Pogosova-Agadjanyan Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
18. N. Kosaka, H. Iguchi, and T. Ochiya Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis Cancer Sci 101 2011 2087 2092
19. D. Joshi, K. Gosh, and B.R. Vundinti MicroRNAs in hematological malignancies: a novel approach to targeted therapy Hematology 17 2012 170 175
20. D. Ichikawa, S. Komatsu, H. Konishi, and E. Otsuji Circulating microRNA in digestive tract cancers Gastroenterology 142 2012 1074-1078 e1071
21. E. Lages, H. Ipas, A. Guttin, H. Nesr, F. Berger, and J.P. Issartel MicroRNAs: molecular features and role in cancer Front Biosci 17 2012 2508 2540
22. Y.W. Kong, D. Ferland-McCollough, T.J. Jackson, and M. Bushell MicroRNAs in cancer management Lancet Oncol 13 2012 e249 e258
23. K. Wang, S. Zhang, B. Marzolf, P. Troisch, A. Brightman, and Z. Hu Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc Natl Acad Sci U S A 106 2009 4402 4407
24. Y. Tomimaru, H. Eguchi, H. Nagano, H. Wada, S. Kobayashi, and S. Marubashi Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma J Hepatol 56 2012 167 175
25. Y. Zhang, Y. Jia, R. Zheng, Y. Guo, Y. Wang, and H. Guo Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases Clin Chem 56 2010 1830 1838
26. Y. Zhang, Y. Liao, D. Wang, Y. He, D. Cao, and F. Zhang Altered expression levels of miRNAs in serum as sensitive biomarkers for early diagnosis of traumatic injury J Cell Biochem 112 2011 2435 2442
27. K.Z. Qu, K. Zhang, H. Li, N.H. Afdhal, and M. Albitar Circulating microRNAs as biomarkers for hepatocellular carcinoma J Clin Gastroenterol 45 2011 355 360
28. J. Xu, C. Wu, X. Che, L. Wang, D. Yu, and T. Zhang Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis Mol Carcinog 50 2011 136 142
29. J. Gui, Y. Tian, X. Wen, W. Zhang, P. Zhang, and J. Gao Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies Clin Sci (Lond) 120 2011 183 193
30. C. Esau, S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, and M. Pear MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab 3 2006 87 98
31. Y. Shan, J. Zheng, R.W. Lambrecht, and H.L. Bonkovsky Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes Gastroenterology 133 2007 1166 1174
32. C.L. Jopling, M. Yi, A.M. Lancaster, S.M. Lemon, and P. Sarnow Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 309 2005 1577 1581
33. J. Krutzfeldt, N. Rajewsky, R. Braich, K.G. Rajeev, T. Tuschl, and M. Manoharan Silencing of microRNAs in vivo with 'antagomirs' Nature 438 2005 685 689
34. H. Xu, J.H. He, Z.D. Xiao, Q.Q. Zhang, Y.Q. Chen, and H. Zhou Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development Hepatology 52 2011 1431 1442
35. A.P. Lewis, and C.L. Jopling Regulation and biological function of the liver-specific miR-122 Biochem Soc Trans 38 2011 1553 1557
36. G. Randall, M. Panis, J.D. Cooper, T.L. Tellinghuisen, K.E. Sukhodolets, and S. Pfeffer Cellular cofactors affecting hepatitis C virus infection and replication Proc Natl Acad Sci U S A 104 2007 12884 12889
37. J.I. Henke, D. Goergen, J. Zheng, Y. Song, C.G. Schuttler, and C. Fehr MicroRNA-122 stimulates translation of hepatitis C virus RNA EMBO J 27 2008 3300 3310
38. R.K. Jangra, M. Yi, and S.M. Lemon Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122 J Virol 84 2011 6615 6625
39. O. Cheung, P. Puri, C. Eicken, M.J. Contos, F. Mirshahi, and J.W. Maher Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression Hepatology 48 2008 1810 1820
40. J. Xu, X. Zhu, L. Wu, R. Yang, Z. Yang, and Q. Wang MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway Liver Int 32 2012 752 760
41. K. Morita, A. Taketomi, K. Shirabe, K. Umeda, H. Kayashima, and M. Ninomiya Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C Liver Int 31 2011 474 484
42. P. Qi, S.Q. Cheng, H. Wang, N. Li, Y.F. Chen, and C.F. Gao Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection PLoS One 6 2011 e28486
43. S. Cermelli, A. Ruggieri, J.A. Marrero, G.N. Ioannou, and L. Beretta Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease PLoS One 6 2011 e23937
44. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
45. V.J. Desmet, M. Gerber, J.H. Hoofnagle, M. Manns, and P.J. Scheuer Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520
46. U. Siebolts, H. Varnholt, U. Drebber, H.P. Dienes, C. Wickenhauser, and M. Odenthal Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR J Clin Pathol 62 2009 84 88
47. I. Wedemeyer, L.P. Bechmann, M. Odenthal, C. Jochum, G. Marquitan, and U. Drebber Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C J Hepatol 50 2009 140 149
48. L. Castera, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
49. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
50. M. Ziol, A. Handra-Luca, A. Kettaneh, C. Christidis, F. Mal, and F. Kazemi Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54
51. M. Sarasin-Filipowicz, J. Krol, I. Markiewicz, M.H. Heim, and W. Filipowicz Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy Nat Med 15 2009 31 33
52. S.H. Hsu, B. Wang, J. Kota, J. Yu, S. Costinean, and H. Kutay Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver J Clin Invest 122 2012 2871 2883
53. W.C. Tsai, S.D. Hsu, C.S. Hsu, T.C. Lai, S.J. Chen, and R. Shen MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis J Clin Invest 122 2012 2884 2897